Business Wire

CEGEDIM

Del
Cegedim Relationship Management Announces Expanded Multichannel Capabilities for Life Sciences Commercial Teams

Cegedim Relationship Management today announced the release of a full multichannel suite via the enhanced integration of the Kadrige iDetailing solution for performing remote interactions, with Cegedim’s Customer Relationship Management (CRM) solution, Mobile Intelligence . The Mobile Intelligence-iDetailing solution addresses the increased demand within the life sciences industry for direct engagement through digital channels.

The Importance of Multichannel Marketing and Remote Detailing in Life Sciences Today
One of the many recent paradigm shifts in the commercial model of life sciences companies is that Health Care Professionals (HCPs) now dictate when and how they want to be marketed to. Life sciences companies must offer a multichannel approach to marketing, which includes both digital and traditional channels, in order to meet the demands of HCPs. One of the digital channels which has become more prevalent is remote detailing, which has increased, for example, by 180% in the US, from 2013 to 2014 (per 2014 study by Cegedim Strategic Data ).

The enhanced Mobile Intelligence-iDetailing integration enables life sciences companies to meet requests for remote interactions. It also addresses the trend in down-sized sales forces, which necessitates improvements in cost efficiency and productivity; the increasing reluctance of HCPs to accept face-to-face visits; and the need to streamline disparate tools for full multichannel customer engagement.

“With iDetailing being seamlessly integrated into Mobile Intelligence, life sciences companies worldwide now have a unified multichannel customer engagement solution which combines the flexibility and experience of Kadrige with the strength and reach of Cegedim,” said Olivier Cadou, Senior Vice President of Cegedim Relationship Management and Founder of Kadrige, which was acquired by Cegedim in January 2014. “Our references are strong. This is a platform our customers trust - a technical solution with proven robustness that won’t let them down during those critical minutes spent with an HCP.”

Kadrige iDetailing is used by thousands of medical representatives to perform remote eDetailing calls with their clients, by Medical Liaisons to perform remote interactions with HCPs, by Clinical Research Associates (CRAs) to recruit physicians or perform studies, and also by KOLs to run interactive web seminars. Nearly 1 million remote detailing sessions have been completed over the past 10 years, in 30 different countries, utilizing Kadrige technology. Compliant and secure, Kadrige iDetailing is available as a web application (SaaS mode) requiring no installation, and as a mobile app for iPad users. In addition to being embedded within Mobile Intelligence, iDetailing is also available as a standalone system, or integrated with any other CRM system.

Please visit the Cegedim Relationship Management website to learn more about the benefits of Kadrige iDetailing and Mobile Intelligence .

     
About Cegedim Relationship Management:  

Cegedim Relationship Management is the Life Sciences industry’s leading provider of Customer Relationship Management (CRM) solutions. Designed specifically for Life Sciences, the company’s innovative business solutions incorporate a thorough understanding of local, regional and worldwide trends. Cegedim Relationship Management enables approximately 200,000 users in many of the world’s most innovative companies to stay ahead of market challenges. In addition to CRM, Cegedim Relationship Management also provides marketing, data optimization and regulatory compliance solutions in more than 80 countries. Cegedim Relationship Management is part of the France-based Cegedim S.A. Group.

 

To learn more, please visit: www.cegedim.com/rm .
Follow Cegedim Relationship Management on LinkedIn and Twitter .

 
About Cegedim:  

Founded in 1969, Cegedim is a global technology and services company specializing in the healthcare field. Cegedim supplies services, technological tools, specialized software, data flow management services and databases. Its offerings are targeted notably at healthcare industries, life sciences companies, healthcare professionals and insurance companies. The world leader in life sciences CRM, Cegedim is also one of the leading suppliers of strategic healthcare industry data. Cegedim employs almost 8,000 people in more than 80 countries and generated revenue of €912 million in 2014. Cegedim SA is listed in Paris (EURONEXT: CGM).

 

To learn more, please visit: www.cegedim.com .
Follow Cegedim on Twitter: @CegedimGroup .

Contact:

Cegedim Relationship Management
Drew BUSTOS, Tel.: +1 (908) 443.2451
Global Communications
drew.bustos@cegedim.com
or
Cegedim
Aude BALLEYDIER, Tel.: +33 (0)1.49.09.68.81
Media Relations
aude.balleydier@cegedim.fr

Link:

ClickThru

Information om Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Følg pressemeddelelser fra Business Wire

Skriv dig op her, og modtag pressemeddelelser på e-mail. Indtast din e-mail, klik på abonner, og følg instruktionerne i den udsendte e-mail.

Flere pressemeddelelser fra Business Wire

Vertex Presents New Data on Benefits of ALYFTREK® and Importance of Achieving Lower Sweat Chloride Levels at the European Cystic Fibrosis Conference6.6.2025 18:00:00 CEST | Press release

- Oral presentation on outcomes following treatment with CFTR modulators show that improvements in CFTR function, as measured by lower sweat chloride, correlate with better outcomes for people with cystic fibrosis - - Oral presentation on new post hoc data from randomized, controlled and open-label trials suggest improved quality of life results with ALYFTREK compared to TRIKAFTA® – Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced data across multiple studies demonstrating positive clinical and quality of life benefits of treatment with CFTR modulators and, in particular, ALYFTREK® (vanzacaftor/tezacaftor/deutivacaftor), which is approved in the United States and United Kingdom and is currently under review with health authorities in the EU, Canada, Australia, New Zealand and Switzerland. These data were presented at this year’s European Cystic Fibrosis Society’s (ECFS) 48th European Cystic Fibrosis Conference held June 4-7, 2025, in Milan, Italy. During the conferenc

Andersen Consulting tilføjer dimension med David and Golyat6.6.2025 16:33:00 CEST | Pressemeddelelse

Andersen Consulting udbygger sin globale konsulentkapacitet gennem en samarbejdsaftale med David and Golyat, en filippinsk konsulentvirksomhed inden for digital strategi. Med et stærkt fokus på business intelligence, kundeindsigt og digital first-eksekvering arbejder David and Golyat med kunder på tværs af flere sektorer – herunder regeringer, udviklingsorganisationer og private virksomheder – for at skabe langsigtet værdi gennem datainformerede beslutninger. Miko David, administrerende partner i David and Golyat, siger: "Vi ser frem til samarbejdet med Andersen Consulting, da det er en milepæl i vores vækstforløb. Ved at kombinere vores ekspertise inden for digital strategi og Andersen Consultings globale platform er vi i stand til at levere endnu større værdi til kunder, der navigerer på komplekse markeder." "Dette samarbejde betyder, at vi kan tilføre en ekstra dimension til vores globale konsulentplatform," siger Mark L. Vorsatz, global bestyrelsesformand og administrerende direktø

IBSA Derma at IMCAS Asia 2025: spotlight on the future of aesthetic medicine in the 10th Anniversary Year of NAHYCO® Technology6.6.2025 16:00:00 CEST | Press release

IBSA Derma, the dermoaesthetic division of Swiss company IBSA, will participate in the 18th IMCAS Asia Congress in Bangkok, gathering over 3,000 professionals from across the region to explore the future of aesthetic and regenerative medicine.With the presence in the Congress and a dedicated scientific symposium, the company reaffirms its commitment to advancing bioremodeling approaches and promoting a holistic, science-driven vision of authentic beauty.This year marks a key milestone for IBSA Derma: 10 years of NAHYCO® Technology, a patented innovation in hyaluronic acid science that continues to shape the future of tissue regeneration. IBSA Derma – the dermoaesthetic division of IBSA – once again confirms its leadership in the international aesthetic medicine landscape by participating in the 18th edition of IMCAS Asia, taking place from June 6 to 8 in Bangkok, Thailand. With over 3,000 attendees expected, the event represents a key opportunity for physicians and experts to share the

HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-Invasive Histotripsy to Treat Kidney Tumors6.6.2025 14:00:00 CEST | Press release

Pivotal Study Advances to Establish Histotripsy as a Non-Thermal, Surgery-Free Alternative to Destroy and Liquefy Kidney Tumors HistoSonics, Inc., the manufacturer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the completion of patient enrollment in its pivotal #HOPE4KIDNEY trial. This prospective, multi-center, single-arm trial is designed to evaluate the safety and effectiveness of the Edison System in destroying kidney tissue by treating primary solid kidney tumors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606659747/en/ Edison Histotripsy System Procedure for Kidney Tumor Animation The trial enrolled patients with a single, non-metastatic solid kidney mass ≤3 cm, confirmed by imaging and biopsy. Subjects will be followed for five years post-procedure, with evaluations at multiple time points, including 14-day, 30-day, 90-day, 180-day, and annual assessments. The Edison

Norwegian Tech Firm Builds Military Command Center in 24 Hours6.6.2025 13:45:00 CEST | Press release

Norwegian technology provider Cyviz has successfully developed a fully mobile and ballistic-proof command center - designed, configured, and made operational in just 24 hours. The solution was showcased during a military exercise led by the Dutch Ministry of Defence and has already sparked interest from NATO members and civil protection agencies across Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250606640770/en/ Cyviz demonstrates rapid deployment capability with a mobile, container-based control room for defense and crisis response Cyviz and its partners constructed the command room inside a 14-ton container designed for transport on standard military vehicles and resistant to machine gun fire. The unit was deployed at a military base in the Netherlands, where Cyviz was tasked with delivering a fully functional command-and-control environment, under strict time constraints and in a high-stakes simulation. "You do

I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter samt finde vores kontaktoplysninger.

Besøg vores nyhedsrum
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye